Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fosamprenavir 700mg tablets
0503010M0AAAAAA
|
Fosamprenavir calcium | Fosamprenavir calcium | Infections | No data available |
|
Foscarnet sodium 6g/250ml solution for infusion bottles
0503022E0AAABAB
|
Foscarnet sodium | Foscarnet sodium | Infections | No data available |
|
Foscavir 6g/250ml solution for infusion bottles
0503022E0BBABAB
|
Foscavir | Foscarnet sodium | Infections | No data available |
|
Fosfocina 500mg capsules
0501130S0BBAAAA
|
Fosfocina | Fosfomycin calcium | Infections | No data available |
|
Fostemsavir 600mg modified-release tablets
0503010AXAAAAAA
|
Fostemsavir | Fostemsavir | Infections | No data available |
|
Fucidin 250mg/5ml oral suspension
0501070M0BBAAAA
|
Fucidin (Liquid) | Fusidic acid | Infections | No data available |
|
Fucidin 500mg inf vials
0501070N0BBACAB
|
Fucidin (Injection/Powder/Tablet) | Sodium fusidate | Infections | No data available |
|
Fungilin 100mg tablets
0502030A0BBAAAC
|
Fungilin (Systemic) | Amphotericin | Infections | No data available |
|
Fungilin 100mg/ml oral suspension
0502030A0BBABAB
|
Fungilin (Systemic) | Amphotericin | Infections | No data available |
|
Furadantin 100mg tablets
0501130R0BBABAE
|
Furadantin | Nitrofurantoin | Infections | No data available |
|
Furadantin 25mg/5ml oral suspension
0501130R0BBACAC
|
Furadantin | Nitrofurantoin | Infections | No data available |
|
Furadantin 50mg tablets
0501130R0BBAAAD
|
Furadantin | Nitrofurantoin | Infections | No data available |
|
Fuzeon 108mg inj vials
0503010J0BBAAAA
|
Fuzeon | Enfuvirtide | Infections | No data available |
|
Gabbroral 250mg tablets
0504050T0BCAAAE
|
Gabbroral | Paromomycin sulfate | Infections | No data available |
|
Galenamox 125mg/5ml oral suspension
0501013B0BHACAS
|
Galenamox | Amoxicillin | Infections | No data available |
|
Galenamox 250mg capsules
0501013B0BHAAAA
|
Galenamox | Amoxicillin | Infections | No data available |
|
Galenamox 250mg/5ml oral suspension
0501013B0BHADAT
|
Galenamox | Amoxicillin | Infections | No data available |
|
Galenamox 500mg capsules
0501013B0BHABAB
|
Galenamox | Amoxicillin | Infections | No data available |
|
Galpharm Single Dose Thrush Treatment 150mg capsules
0502010B0BCAAAB
|
Galpharm (Fluconazole) | Fluconazole | Infections | No data available |
|
Ganciclovir 250mg capsules
0503022D0AAACAC
|
Ganciclovir | Ganciclovir | Infections | No data available |
|
Ganciclovir 500mg capsules
0503022D0AAADAD
|
Ganciclovir | Ganciclovir | Infections | No data available |
|
Ganciclovir 500mg powder for solution for infusion vials
0503022D0AAAAAA
|
Ganciclovir | Ganciclovir | Infections | No data available |
|
Generic Deteclo 300mg tablets
0501030X0AAAAAA
|
Generic tablet | Tetracycline combined preparations | Infections | No data available |
|
Generic Mictral granules 7g sachets
0501120N0AAACAC
|
Nalidixic acid | Nalidixic acid | Infections | No data available |
|
Generic National 30 day HIV post exposure prophylaxis pack
0503010AYAAAAAA
|
Raltegravir/Emtricitabine/Tenofovir disoproxil | Raltegravir/Emtricitabine/Tenofovir disoproxil | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.